Search Results - "Sader, H.S."

P68 Ceftazidime–avibactam activity tested against Gram-negative bacterial pathogens in the Asia-Pacific region and South Africa (2010) by Flamm, R.K, Sader, H.S, Jones, R.N

Get full text

P65 Daptomycin activity when tested against uncommonly isolated streptococcal species and three other Gram-positive species groups by Sader, H.S, Flamm, R.K, Jones, R.N

Get full text

P64 Ceftaroline activity against common bacterial pathogens causing skin and soft tissue infections in the Asia-Pacific region and South Africa by Sader, H.S, Jones, R.N, Flamm, R.K

Get full text

P67 Activity of ceftaroline tested against recent (2011) respiratory tract infection pathogens from the Asia Pacific region and South Africa by Sader, H.S, Flamm, R.K, Jones, R.N

Get full text

P66 Antimicrobial activity of ceftazidime–avibactam tested against Pseudomonas aeruginosa from China (2009–2010) by Flamm, R.K, Jones, R.N, Sader, H.S, Wang, Y, Xu, Y

Get full text

Eight-year (2002-2009) Summary of the Linezolid (Zyvox® Annual Appraisal of potency and Spectrum; ZAAPS) Program in European Countries by Ross, J.E., Farrell, D.J., Mendes, R.E., Sader, H.S., Jones, R.N.

“…The linezolid surveillance network (ZAAPS program) has been monitoring linezolid activity and susceptibility rates for eight years (2002-2009) in European…”
Get full text

Antimicrobial Activity of Daptomycin Tested Against Gram-Positive Strains Collected in European Hospitals: Results from 7 Years of Resistance Surveillance (2003-2009) by Sader, H.S., Farrell, D.J., Jones, R.N.

“…Daptomycin is a cyclic lipopeptide approved by the European medicines Agency (EMEA) for the treatment of complicated skin and soft tissue infections (cSSTI)…”
Get full text

Screening of antibacterial extracts from plants native to the Brazilian Amazon Rain Forest and Atlantic Forest by Suffredini, I B, Sader, H S, Gonçalves, A G, Reis, A O, Gales, A C, Varella, A D, Younes, R N

“…More than 20% of the world's biodiversity is located in Brazilian forests and only a few plant extracts have been evaluated for potential antibacterial…”
Get full text

International surveillance of blood stream infections due to Candida species in the European SENTRY program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents by Pfaller, M.A, Jones, R.N, Doern, G.V, Fluit, A.C, Verhoef, J, Sader, H.S, Messer, S.A, Houston, A, Coffman, S, Hollis, R.J

“…The SENTRY Antimicrobial Surveillance Program, an international study of blood stream infections (BSIs), detected 170 episodes of candidemia in 20 European…”
Get full text

Metallo-β-lactamase IMP-18 is located in a class 1 integron (In96) in a clinical isolate of Pseudomonas aeruginosa from Mexico by Garza-Ramos, U, Tinoco, P, Silva-Sanchez, J, Morfin-Otero, R, Rodriguez-Noriega, E, Leon-Garnica, G, Sader, H.S, Jones, R.N

Get full text

Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY antimicrobial surveillance program by Pfaller, M.A, Jones, R.N, Doern, G.V, Sader, H.S, Kugler, K.C, Beach, M.L

“…The SENTRY Antimicrobial Surveillance Program was established in January, 1997 to monitor the predominant pathogens and antimicrobial resistance patterns of…”
Get full text

Daptomycin activity against Gram-Positive Cocci isolated in United Kingdom medical centers by Bowker, K.E, MacGowan, A, French, G, Lindsay, G, Sader, H.S, Jones, R.N

Get full text

Impact of EUCAST, CLSI and USCAST ceftaroline breakpoint changes on the susceptibility of methicillin-resistant Staphylococcus aureus isolates collected from US medical centres (2015–2018) by Sader, H.S., Jones, R.N.

Get full text

Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in the Asia-Pacific region (minus China, Australia and New Zealand): report from an Antimicrobial Surveillance Programme (2013–2015) by Pfaller, M.A., Shortridge, D., Sader, H.S., Castanheira, M., Flamm, R.K.

“…•Ceftolozane/tazobactam (C/T) and meropenem were the most active compounds tested against Enterobacteriaceae.•C/T showed good activity against ESBL non-CRE…”
Get full text

Antimicrobial activity of ceftobiprole and comparator agents when tested against contemporary Gram-positive and -negative organisms collected from Europe (2015) by Pfaller, M.A., Flamm, R.K., Duncan, L.R., Streit, J.M., Castanheira, M., Sader, H.S.

“…Susceptibility testing of ceftobiprole and comparators against 12,240 isolates was performed following CLSI/EUCAST guidelines. The percentage of susceptible…”
Get full text

Oritavancin in vitro activity against gram-positive organisms from European and United States medical centers: results from the SENTRY Antimicrobial Surveillance Program for 2010–2014 by Pfaller, M.A., Sader, H.S., Flamm, R.K., Castanheira, M., Mendes, Rodrigo E.

“…The in vitro activity of oritavancin was assessed against 44,715 gram-positive pathogens causing infections in European and United States (US) hospitals…”
Get full text

Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001–2004) by Gales, A.C., Jones, R.N., Sader, H.S.

“…In total, 54 731 Gram-negative bacilli isolated worldwide between 2001 and 2004 from diverse sites of infection were tested for susceptibility to polymyxin B…”
Get full text

Antimicrobial Activity of Tigecycline and Cefoperazone/Sulbactam Tested against 18,386 Gram-negative Organisms from Europe and the Asia-Pacific Region (2013–2014) by Pfaller, MA, Flamm, RK, Duncan, LR, Mendes, RE, Jones, RN, Sader, HS

“…ABSTRACT A total of 18,386 organisms, including 13,224 Enterobacteriaceae, 3536 Pseudomonas aeruginosa , 1254 Acinetobacter spp., and 372 Stenotrophomonas…”
Get full text

Antimicrobial susceptibility of Gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002–2004) by Sader, H.S., Streit, J.M., Fritsche, T.R., Jones, R.N.

“…The antimicrobial susceptibility patterns of 9322 contemporary (2002–2004) Gram-positive bacterial isolates collected from 31 medical centres in 14 countries…”
Get full text

Ceftolozane–tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Australia and New Zealand: Report from an Antimicrobial Surveillance Program (2013–2015) by Pfaller, M.A., Shortridge, D., Sader, H.S., Flamm, R.K., Castanheira, M.

“…•Ceftolozane–tazobactam (C–T), meropenem and amikacin were the most active compounds tested against Enterobacteriaceae.•Ceftolozane–tazobactam showed good…”
Get full text